Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmad Awada

Showing results (181-190 of 311) with videos related to

Pageof 32
Sort By:
Breast Cancer Research and Treatment|November 15, 2015
Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trialJavier Cortes, Stacie Hudgens, Chris Twelves, et al.
Frontiers in Medicine|May 22, 2023
The benefit of co-targeting PARP-1 and c-Met on the efficacy of radiotherapy in wild type BRAF melanomaMalak Sabbah, Ahmad Najem, Christophe Vanderkerkhove, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2011
A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancerErica L Mayer, Jean-Francois Baurain, Joseph Sparano, et al.
Breast Cancer Research and Treatment|April 5, 2020
Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitorsMaria Alice Franzoi, Caroline Vandeputte, Daniel Eiger, et al.
Breast (Edinburgh, Scotland)|February 17, 2012
Clinical and pharmacokinetic study of sunitinib and docetaxel in women with advanced breast cancerJonas Bergh, Gabriella Mariani, Fatima Cardoso, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 29, 2025
Neoadjuvant chemotherapy with bevacizumab for locally advanced vulvar cancerTheresa M Kuhn, Sarfraz Ahmad, Fernando O Recio, et al.
Archives of Dermatological Research|January 13, 2005
Expression of galectin-3 in primary and metastatic melanoma: immunohistochemical studies on human lesions and nude mice xenograft tumorsPierre Vereecken, Charles Debray, Michel Petein, et al.
Breast (Edinburgh, Scotland)|July 29, 2014
A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study)Pierre Fumoleau, Kevin M Koch, Etienne Brain, et al.
Cancers|August 4, 2019
The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in MelanomaMohammad Krayem, Malak Sabbah, Ahmad Najem, et al.
Critical Reviews in Oncology/Hematology|December 3, 2021
Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinibAhmad Awada, Thierry Berghmans, Paul M Clement, et al.
Pageof 32

Showing results (181-190 of 311) with videos related to

Sort By:
Pageof 32
Breast Cancer Research and Treatment|November 15, 2015
Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trialJavier Cortes, Stacie Hudgens, Chris Twelves, et al.
Frontiers in Medicine|May 22, 2023
The benefit of co-targeting PARP-1 and c-Met on the efficacy of radiotherapy in wild type BRAF melanomaMalak Sabbah, Ahmad Najem, Christophe Vanderkerkhove, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2011
A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancerErica L Mayer, Jean-Francois Baurain, Joseph Sparano, et al.
Breast Cancer Research and Treatment|April 5, 2020
Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitorsMaria Alice Franzoi, Caroline Vandeputte, Daniel Eiger, et al.
Breast (Edinburgh, Scotland)|February 17, 2012
Clinical and pharmacokinetic study of sunitinib and docetaxel in women with advanced breast cancerJonas Bergh, Gabriella Mariani, Fatima Cardoso, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 29, 2025
Neoadjuvant chemotherapy with bevacizumab for locally advanced vulvar cancerTheresa M Kuhn, Sarfraz Ahmad, Fernando O Recio, et al.
Archives of Dermatological Research|January 13, 2005
Expression of galectin-3 in primary and metastatic melanoma: immunohistochemical studies on human lesions and nude mice xenograft tumorsPierre Vereecken, Charles Debray, Michel Petein, et al.
Breast (Edinburgh, Scotland)|July 29, 2014
A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study)Pierre Fumoleau, Kevin M Koch, Etienne Brain, et al.
Cancers|August 4, 2019
The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in MelanomaMohammad Krayem, Malak Sabbah, Ahmad Najem, et al.
Critical Reviews in Oncology/Hematology|December 3, 2021
Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinibAhmad Awada, Thierry Berghmans, Paul M Clement, et al.
Pageof 32